SAN FRANCISCO, Calif-Drugs that were once touted as the cure to cancer have shown only a slight benefit in testing.
The dramatic tumor shrinkage or disappearance that doctors originally predicted from drugs has not happened in trial studies. The three drugs discovered within Judah Folkman's, MD, lab are within a new field pioneered by the physician and his team. Angiogensis, which starves tumors with chemicals and stops them form building new blood vessels, includes endostatin and angiostatin drugs. Both drugs were discovered by Michael O'Reilly, MD.
An article in The New York Times incorrectly labeled these new drugs as a possible cancer cure. However, only in a few cases have the drugs stopped growing cancer. In some cases the drug has halted cancer in some parts of the body, while having little effect elsewhere. The drugs do seem to slow the flow of blood to the patient's tumor.
The researchers will move on with these drugs and see if they are more effective when combined with chemotherapy and radiation.
Information from www.washingtonpost.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.